2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
CNS
1
Conditions
Brain Neoplasms
2313
Glioblastoma
2016
Glioma
1402
Central Nervous System Neoplasms
692
Astrocytoma
668
Neuroblastoma
647
Gliosarcoma
480
Oligodendroglioma
405
Neoplasms
405
Breast Neoplasms
327
Medulloblastoma
307
Carcinoma, Non-Small-Cell Lung
256
Meningioma
229
Recurrence
224
Sarcoma
215
Melanoma
207
Neoplasm Metastasis
202
Ependymoma
200
Lung Neoplasms
199
Neurofibromatosis 1
169
Lymphoma
162
Meningeal Carcinomatosis
138
Osteosarcoma
135
Ovarian Neoplasms
132
Wilms Tumor
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
123
Head and Neck Neoplasms
117
Lymphoma, Non-Hodgkin
116
Diffuse Intrinsic Pontine Glioma
113
Rhabdomyosarcoma
107
Interventions
sargramostim
1
Temozolomide
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tetanus
×
CNS
×
Clear all
NCT03927222
2024-04-08
I-ATTAC
Duke University
Phase 2
Terminated
6 enrolled
7 charts